GB Patent

GB201516905D0 — Treatment of Neurodegenerative diseases

Assigned to BenevolentAI Bio Ltd · Expires 2015-11-11 · 11y expired

What this patent protects

Patent listed against Vizimpro.

Drugs covered by this patent

Vizimpro (Dacomitinib) · Pfizer Inc.

Patent Metadata

Patent number: GB201516905D0
Jurisdiction: GB
Classification: —
Expires: 2015-11-11
Drug substance claim: No
Drug product claim: No
Assignee: BenevolentAI Bio Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.